SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-007420
Filing Date
2022-05-04
Accepted
2022-05-04 16:41:30
Documents
14
Period of Report
2022-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K freq-20220504.htm   iXBRL 8-K 59256
2 EX-99.1 freq-ex99_1.htm EX-99.1 128511
3 GRAPHIC img198726637_0.jpg GRAPHIC 7757
  Complete submission text file 0000950170-22-007420.txt   338749

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT freq-20220504.xsd EX-101.SCH 2497
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT freq-20220504_lab.xml EX-101.LAB 18615
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT freq-20220504_pre.xml EX-101.PRE 11608
8 EXTRACTED XBRL INSTANCE DOCUMENT freq-20220504_htm.xml XML 4891
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 22892181
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences